PAPER Fernandez-Echevarria C, Díaz M, Ferrer I, Canerina-Amaro A, Marin R

Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.

Neuroscience. 2014 Oct 10;278:354-66. Epub 2014 Aug 26 PubMed: 25168729

PAPER Wu Z, Nakanishi H

Connection between periodontitis and Alzheimer's disease: possible roles of microglia and leptomeningeal cells.

J Pharmacol Sci. 2014;126(1):8-13. Epub 2014 Aug 29 PubMed: 25168594

PAPER Conrado DJ, Denney WS, Chen D, Ito K

An updated Alzheimer's disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM.

J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):581-98. Epub 2014 Aug 29 PubMed: 25168488

PAPER Haupt C, Fändrich M

Biotechnologically engineered protein binders for applications in amyloid diseases.

Trends Biotechnol. 2014 Oct;32(10):513-20. Epub 2014 Aug 26 PubMed: 25168412

PAPER Jones RS, Lynch MA

How dependent is synaptic plasticity on microglial phenotype?

Neuropharmacology. 2014 Aug 27; PubMed: 25168262

PAPER Daulatzai MA

Role of stress, depression, and aging in cognitive decline and Alzheimer's disease.

Curr Top Behav Neurosci. 2014;18:265-96. PubMed: 25167923

PAPER Ngoungoure VL, Schluesener J, Moundipa PF, Schluesener H

Natural polyphenols binding to amyloid: a broad class of compounds to treat different human amyloid diseases.

Mol Nutr Food Res. 2015 Jan;59(1):8-20. Epub 2014 Oct 9 PubMed: 25167846

PAPER Öhman H, Savikko N, Strandberg TE, Pitkälä KH

Effect of physical exercise on cognitive performance in older adults with mild cognitive impairment or dementia: a systematic review.

Dement Geriatr Cogn Disord. 2014;38(5-6):347-65. Epub 2014 Aug 21 PubMed: 25171577

PAPER Hessler J, Tucha O, Förstl H, Mösch E, Bickel H

Age-correction of test scores reduces the validity of mild cognitive impairment in predicting progression to dementia.

PLoS One. 2014;9(8):e106284. Epub 2014 Aug 29 PubMed: 25171483

PAPER Malec-Litwinowicz M, Rudzińska M, Szubiga M, Michalski M, Tomaszewski T, Szczudlik A

Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients.

Neurol Neurochir Pol. 2014;48(4):258-61. Epub 2014 Jul 29 PubMed: 25168325

John Adams

Canadian PKU and Allied Disorders
Toronto , Canada

Richard van den Broek

United States

Daryl Wilson

United States

PAPER Milosch N, Tanriöver G, Kundu A, Rami A, François JC, Baumkötter F, Weyer SW, Samanta A, Jäschke A, Brod F, Buchholz CJ, Kins S, Behl C, Müller UC, Kögel D

Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.

Cell Death Dis. 2014 Aug 28;5:e1391. PubMed: 25165877

PAPER Fernandes JT, Tenreiro S, Gameiro A, Chu V, Outeiro TF, Conde JP

Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator.

Lab Chip. 2014 Oct 21;14(20):3949-57. PubMed: 25167219